TDAC
Translational Development Acquisition Corp. Ordinary SharesNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$234.85M
P/E Ratio
38.29
EPS
$0.28
Beta
—
52W High
$10.80
52W Low
$10.25
50-Day MA
$10.66
200-Day MA
$10.51
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Translational Development Acquisition Corp. Ordinary Shares
Trident Acquisitions Corp. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.31% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.47 |
| Price-to-Book | 1.33 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -10.10% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $17.25M |
| Float | $14.70M |
| % Insiders | 0.00% |
| % Institutions | 101.52% |
Historical Volatility
HV 10-Day
2.32%
HV 20-Day
3.71%
HV 30-Day
3.04%
HV 60-Day
2.94%
HV Rank
96.0%
Volatility is currently contracting
More FINANCIAL SERVICES Stocks
Data last updated: 6/13/2026